

A practical guide for providers on helping patients find Podofilox in stock. Includes 5 actionable steps, alternatives, and workflow tips.
You've prescribed Podofilox (Condylox) for a patient with external genital warts, and now they're calling back: "My pharmacy doesn't have it." It's a scenario that's become all too common in 2026, and it puts providers in a difficult position.
This guide gives you a practical, step-by-step approach to helping your patients access Podofilox — or an appropriate alternative — with minimal disruption to your workflow.
Podofilox 0.5% (both the topical solution and gel formulations) has experienced intermittent supply disruptions. Key facts for your practice:
Understanding the barriers helps you guide patients more effectively:
Because Podofilox is a niche dermatological product, many pharmacies — especially large chains — don't maintain regular inventory. Patients often learn it's unavailable only after arriving at the pharmacy.
Even when a pharmacy tries to order Podofilox, their primary wholesaler may be out of stock. Pharmacies that rely on a single wholesaler have no fallback option.
Many patients don't know that they can check stock before visiting a pharmacy, that independent pharmacies may be a better option, or that their prescription can be transferred to another location. This is where your guidance makes a real difference.
The most impactful thing you can do is proactively tell patients that Podofilox may be difficult to find. This simple step prevents frustration and prepares them to take action rather than feeling helpless.
Consider saying something like: "Podofilox has had some supply issues lately. If your pharmacy doesn't have it in stock, here's what you can do..."
Recommend that patients use Medfinder to check which pharmacies near them currently have Podofilox in stock. This is faster and more reliable than calling pharmacies one by one.
You can even integrate this into your after-visit instructions: "Check Medfinder.com to find a pharmacy with Podofilox in stock before you go."
If clinically appropriate, consider the following approaches:
Before the patient leaves your office, discuss what to do if they can't find Podofilox within a reasonable timeframe (e.g., one week):
Be prepared to pivot quickly. The most common alternatives for external genital warts include:
For a detailed comparison, see our provider shortage briefing.
Integrating these strategies into your workflow doesn't have to be burdensome. Here are some practical tips:
Develop a one-page patient handout that includes:
Create an EHR template or smart phrase for genital wart treatment that includes availability guidance. This saves time and ensures consistent patient communication.
If you're in a multi-provider practice, designate a staff member (medical assistant, nurse) who can handle "I can't find my medication" calls efficiently. They should know:
Keep a simple log of which pharmacies successfully fill Podofilox prescriptions. Over time, this gives you reliable referral options for future patients.
The Podofilox supply situation is beyond any individual provider's control, but the patient experience is not. By setting expectations early, directing patients to the right tools, prescribing flexibly, and having alternatives ready, you can ensure your patients get treated promptly — even when their first-choice medication is in short supply.
For real-time Podofilox availability data and provider tools, visit Medfinder for Providers. For patient resources, share our guides on finding Podofilox in stock and saving money on Podofilox.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.